Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New device could make DVT monitoring safer and simpler

NCT ID NCT07665320

Knowledge-focused Sponsor: Tampere University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 30, 2026 · Updated 2 times

Summary

This study is testing a new, non-invasive device that uses electrical signals to measure blood flow in the legs. It includes 20 healthy volunteers and 20 patients with deep vein thrombosis (DVT) who are undergoing clot-busting treatment. The goal is to collect data to improve the device and train AI to better detect blood flow changes.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could lead to a better, non-invasive way to monitor deep vein thrombosis during treatment.
What could go wrong
This is a small, early-stage study focused on data collection, not treatment. The device may not prove accurate enough for clinical use.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 40 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jul 2025

Expected to finish

Dec 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Tampere

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria for Patients group: * Age: 18 or older; * DVT detected on other lower limb; * Suitable for CDT treatment; * Ability to give informed consent; * Volunteering for the study. Exclusion Criteria for Patients group: * Age under 18 years; * Inability to give informed consent; * Denial; * Too injured skin in the measurement area Inclusion Criteria for Healthy volunteers group: * Age: 18 or older; * Ability to give informed consent; * Volunteering for the study Exclusion Criteria for Healthy volunteers group: * Diagnosed DVT in lower limbs; * Age under 18 years; * Inability to give informed consent; * Denial; * Too injured skin in the measurement area.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Deep vein thrombosis (DVT) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

venous thromboembolism Venous Thrombosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Deep vein thrombosis (DVT)

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Tampere University

    COMPLETED

    Tampere, Finland

  • Tampere University Hospital

    RECRUITING

    Tampere, Finland

More trials for these conditions

Other studies related to the condition(s) this trial covers.